The new Site Selection Report for Life Sciences Companies, compiled by KPMG in association with Venture Valuation, explores the when, where and how of successful European expansion. This popular report looks beyond site selection to include key work streams involved in successfully commercializing pharmaceutical products in Europe. In the 2018 edition of the Site Selection for Life Sciences Companies in Europe Report, we identify five key work streams involved in building a successful operating model. This popular site selection analysis compares the attractiveness of different European countries, focusing on the most relevant factors such as innovation, infrastructure, taxation and incentives.
Would you like to be notified about new reports and other valuable content published by Venture Valuation?